Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Strong Buy: Aurora Cannabis Shares Receives Bump from Analyst Recommendation, Tumbles with Sector after FDA Chief Resigns

Aurora Cannabis (NYSE: ACB)Strong Buy: Aurora Cannabis Shares Receives Bump from Analyst Recommendation, Tumbles with Sector after FDA Chief Resigns has been put between what could be considered as a rock and a hard place. The company, recently favored by Cowen & Co analysts, immediately faced decreases in value that similar cannabis corporations within the cannabis sector felt today. Cannabis stocks fell across the board after FDA Chief Dr. Scott Gottlieb announced his resignation.

Despite the news: we would recommend purchasing shares in ACB at this time.

Vivien Azer, established analyst at Cowen & Co, placed an Outperform rating on Aurora Cannabis with a price point target of $10.50 or C$14. Cowen analysts touted the company’s ability to capture 20% of the Canadian cannabis market share and its large cultivation footprint of 575,000kg.

{{cta(’69f63bd3-e695-415f-8c83-b207c29317a6′)}}

“While establishing 20% market share has been an early success story in Canadian adult use cannabis, the company is uniquely positioned to drive leadership in both share and profitability,” said Azer.

ACB shares peaked at $8.42 today, before it tumbled, and is currently at a 9.29% increase after market close on Monday of this week. After the Cowen announcement, the value of ACB rose more than 12% on Tuesday, and continued for another 2.59% until it hit the $8.42 peak in value on Wednesday.

Curious about other cannabis stocks with massive growth potential? Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll keep you informed on all things cannabis and even help you determine which cannabis companies have the highest growth potential.

Source

Strong Buy: Aurora Cannabis Shares Receives Bump from Analyst Recommendation, Tumbles with Sector after FDA Chief Resigns

Cannin Investment Group: Your Hemp Stocks Experts

Cannin.com is your trusted resource for hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. Our team aggregates hundreds of hours of market research to provide tips on the best hemp stocks for 2020. 

Use Cannin as your resource for:

Is it too late to invest in hemp stocks? No! This is the perfect time to invest.

Wall street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now. 

Are you interested in hemp stocks like GW Pharmaceuticals, Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Are you looking to buy stock in hemp companies or marijuana companies in 2020? Interested in emerging penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks to invest in? We can help.

Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +25% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012

At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best hemp stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Hemp stocks

Strong Buy: Aurora Cannabis Shares Receives Bump from Analyst Recommendation, Tumbles with Sector after FDA Chief Resigns